Myobloc

被引：14
作者：
Flynn, TC
机构：
[1] Cary Skin Ctr, Cary, NC 27519 USA
[2] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27514 USA
来源：
DERMATOLOGIC CLINICS | 2004年 / 22卷 / 02期
关键词：
D O I：
10.1016/S0733-8635(03)00070-6
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Myobloc is the currently available commercial formulation of type B botulinum toxin. Released in the United States in 2000, it is approved by the Food and Drug Administration for the treatment of cervical dystonia. The most commonly used botulinum toxins, the type A toxins (Botox(R) and Dysport(R)), affect the SNAP-25 protein, whereas the type B toxin (Myobloc(R)) affects vesicle-associated membrane protein, also known as synaptobrevin. Both type B and type A are antigenically distinct. This article explains the difference between Myobloc(R) and type A toxins, reviews equivalency and other published studies, and describes practical uses for this product in facial aesthetics.
引用
收藏
页码：207 / +
页数：6
相关论文
共 16 条
[1]   Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A [J].
Alster, TS ;
Lupton, JR .
DERMATOLOGIC SURGERY, 2003, 29 (05) :516-518
[2]   A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice [J].
Aoki, KR .
TOXICON, 2001, 39 (12) :1815-1820
[3]  
AREZZO JL, 2002, MOVEMENT DISORD, V15, P159
[4]   Botulinum toxin type B (Myobloc) [J].
Baumann, L ;
Black, L .
DERMATOLOGIC SURGERY, 2003, 29 (05) :496-500
[5]   A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of myobloc (Botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: A double-blinded, placebo-controlled trial [J].
Baumann, L ;
Slezinger, A ;
Vujevich, J ;
Halem, M ;
Bryde, J ;
Black, L ;
Duncan, R .
DERMATOLOGIC SURGERY, 2003, 29 (05) :508-515
[6]   Botulinum toxin type B: An overview of its biochemistry and preclinical pharmacology [J].
Callaway, JE ;
Arezzo, JC ;
Grethlein, AJ .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2001, 20 (02) :127-136
[7]   Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: Rate of onset and radius of diffusion [J].
Flynn, TC ;
Clark, RE .
DERMATOLOGIC SURGERY, 2003, 29 (05) :519-522
[8]   Pharmacology of botulinum toxin [J].
Huang, W ;
Foster, JA ;
Rogachefsky, AS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (02) :249-259
[9]  
Lew MF, 2000, NEUROLOGY, V55, pS29
[10]  
Lowe NJ, 2003, J COSMET LASER THER, V4, P15
12